Cocrystal Pharma, Inc.
COCP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001412486
In the last 90 days, Cocrystal Pharma, Inc. insiders filed 2 open-market purchases and 0 sales; 27 institutions reported holding it in 13F filings for Q2 2026, worth $1.17M in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in Cocrystal Pharma, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 14
- −2 vs. Q1 2024
- Shares held
- 674.4K
- −47.2K (−6.5%) vs. Q1 2024
- Total value
- $1.57M
- +$557.3K (+55.0%) vs. Q1 2024
- New holders
- 1
- 4 more added
- Sold out
- 3
- 5 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting COCP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 27 | $1.17M |
| Q1 2026 | 26 | $783.8K |
| Q4 2025 | 28 | $754.3K |
| Q3 2025 | 22 | $831.3K |
| Q2 2025 | 22 | $1.02M |
| Q1 2025 | 24 | $1.06M |
| Q4 2024 | 24 | $1.44M |
| Q3 2024 | 20 | $1.27M |
| Q2 2024 | 14 | $1.57M |
| Q1 2024 | 16 | $1.18M |
| Q4 2023 | 17 | $1.28M |
| Q3 2023 | 16 | $1.32M |
| Q2 2023 | 20 | $1.59M |
| Q1 2023 | 21 | $1.47M |
| Q4 2022 | 21 | $2.08M |
| Q3 2022 | 27 | $3.99M |
| Q2 2022 | 33 | $5.83M |
| Q1 2022 | 34 | $7.90M |
| Q4 2021 | 35 | $9.78M |
| Q3 2021 | 41 | $16.1M |
| Q2 2021 | 42 | $25.0M |
| Q1 2021 | 35 | $13.5M |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Cocrystal Pharma, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 275,656 | $642.3K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 129,828 | $302.5K | 0.00% | +3,800+3.0% | Added |
| BlackRock Inc. | 73,746 | $171.8K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 64,832 | $151.1K | 0.00% | +4,400+7.3% | Added |
| Morgan Stanley | 59,300 | $138.2K | 0.00% | +290.0% | Added |
| Susquehanna International Group, LLP | 25,052 | $58.4K | 0.00% | −27,078−51.9% | Reduced |
| State Street Corp | 20,543 | $47.9K | 0.00% | −3,900−16.0% | Reduced |
| Northern Trust Corp | 12,171 | $28.4K | 0.00% | −36−0.3% | Reduced |
| Bank of America Corp | 9,033 | $21.0K | 0.00% | +58+0.6% | Added |
| Tower Research Capital LLC (TRC) | 3,681 | $8.58K | 0.00% | −3,775−50.6% | Reduced |
| JPMorgan Chase & Co | 428 | $997 | 0.00% | −115−21.2% | Reduced |
| NVWM, LLC | 84 | $196 | 0.00% | 00.0% | Unchanged |
| Activest Wealth Management | 1 | $2 | 0.00% | +1 | New |
| Royal Bank of Canada | 51 | $0 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 0 | $0 | 0.00% | −20,258−100.0% | Sold out |
| Vima LLC | 0 | $0 | 0.00% | −231−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −93−100.0% | Sold out |